Buscar resultados de ensayos clínicos
Geographic Atrophy - 34 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy Condición: Geographic Atrophy Fecha: 2010-10-25 Intervenciones:
|
Recruiting |
Nombre del estudio: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima B) Condición: Geographic Atrophy Fecha: 2015-03-23 Intervenciones: Other: No intervention No intervention administered in this study |
Recruiting |
Nombre del estudio: Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) Condición: Geographic Atrophy Fecha: 2016-04-18 Intervenciones: Drug: Lampalizumab Lampalizumab 10 mg will be administered every 4 or 6 weeks according to the frequency |
Recruiting |
Nombre del estudio: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A). Condición: Geographic Atrophy Fecha: 2015-06-19 Intervenciones: Other: No intervention No intervention administered in this study |
Recruiting |
Nombre del estudio: Micropulse Laser for Geographic Atrophy Condición:
Fecha: 2013-02-25 Intervenciones: Procedure: Micropulse Between 1 and 3 sessions of micropulse laser will be applied in the inferior hemir |
Completed |
Nombre del estudio: Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Condición:
Fecha: 2007-01-30 Intervenciones: Drug: Fenretinide Once daily 30 minutes after the evening meal for 24 months |
Terminated |
Nombre del estudio: Geographic Atrophy Treatment Evaluation Condición:
Fecha: 2009-04-27 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride Condición: Geographic Atrophy Fecha: 2013-02-28 Intervenciones:
|
Completed |
Nombre del estudio: Geographic Atrophy and Intravitreal Ranibizumab Injections Condición:
Fecha: 2015-02-20 Intervenciones: Drug: Ranibizumab The medication Ranibizumab is routine standard of care for patients with wet AMD, and |
Recruiting |
Nombre del estudio: A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Condición:
Fecha: 2016-02-16 Intervenciones:
|